A Bennett Jenson

Title: A Bennett Jenson: Innovator in Parvovirus Treatment

Introduction

A Bennett Jenson is a notable inventor based in Louisville, KY (US). He has made significant contributions to the field of medical research, particularly in the treatment and prevention of parvovirus infections. With a total of 3 patents to his name, Jenson's work has the potential to impact veterinary and human health.

Latest Patents

Jenson's latest patents focus on compositions and methods for treating, including preventing, parvovirus infections and related diseases. Some embodiments of his invention include inventive polypeptides, such as mutant VP2 proteins, and virus-like particles made from these polypeptides. Other aspects of his work involve compositions designed to treat or prevent parvovirus infections, specifically erythrovirus or parvovirus B19. Furthermore, he has developed methods for administering these compositions to animals, along with nucleic acid sequences that encode the inventive polypeptides.

Career Highlights

Throughout his career, Jenson has been associated with the University of Louisville Research Foundation, Inc. His innovative research has contributed to advancements in the understanding and treatment of viral infections.

Collaborations

Jenson has collaborated with notable colleagues, including Shin-je Ghim and John Olaf Trent. Their combined expertise has likely enhanced the quality and impact of their research endeavors.

Conclusion

A Bennett Jenson's work in developing treatments for parvovirus infections showcases his dedication to advancing medical science. His innovative patents and collaborations highlight the importance of research in combating viral diseases.